Home/Filings/4/0001209191-22-054976
4//SEC Filing

Wood David S. 4

Accession 0001209191-22-054976

CIK 0001633932other

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 11:09 AM ET

Size

5.4 KB

Accession

0001209191-22-054976

Insider Transaction Report

Form 4
Period: 2022-06-29
Wood David S.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-29+90,00090,000 total
    Exercise: $3.60Exp: 2032-06-29Common Shares (90,000 underlying)
Footnotes (1)
  • [F1]One-fourth vests after 12 months from the date of grant with the remaining three-fourths vesting in 36 equal installments with the first installment vesting at the end of the 13th month and subsequent installments vesting every one month anniversary thereafter.

Issuer

ESSA Pharma Inc.

CIK 0001633932

Entity typeother

Related Parties

1
  • filerCIK 0001826902

Filing Metadata

Form type
4
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 11:09 AM ET
Size
5.4 KB